Alcon AcrySof多焦点人工晶体双侧植入术后的临床结局

Clinical outcomes after bilateral implantation of an apodized +3.0 D toric diffractive multifocal intraocular lens
2014-03-13 12:10发表评论
期刊: J CATARACT REFR SURG2014年1月1期40卷

PURPOSE: To assess visual outcomes after bilateral implantation of an apodized +3.0 diopter (D) addition power toric diffractive multifocal intraocular lens (IOL).

SETTING: Five study sites in Europe and South America.

DESIGN: Cohort study.

METHODS: Patients had bilateral implantation of the AcrySof(®) IQ ReSTOR(®)+3.0 D toric multifocal IOL. Inclusion criteria were age from 21 to 70 years, need for bilateral cataract extraction or refractive lens exchange, and regular corneal astigmatism from 0.75 to 2.5 D. Six-month evaluations included spherical equivalent (SE), refractive and corneal cylinder, visual acuity at various distances, defocus testing, reading speed, and IOL rotation.

RESULTS: Forty-four of 49 patients completed the 6-month visit. The mean SE (88 eyes) was 0.09 D ± 0.49 (SD) at 6 months (±1.00 D in 95.2%). The mean refractive cylinder decreased from 1.07 ± 0.71 D to 0.33 ± 0.44 D (≤0.50 D in 78.6% and ≤1.00 D in 92.9%). The mean binocular uncorrected visual acuity was 0.04 ± 0.08 logMAR at preferred near (∼39 cm), 0.07 ± 0.09 logMAR at 40 cm, 0.09 ± 0.11 logMAR at 60 cm, and 0.05 ± 0.10 logMAR at 4 m. The mean corrected reading speed increased from 125.43 ± 33.58 words per minute (wpm) to 132.68 ± 23.69 wpm. The mean IOL rotation was 2.20 ± 4.34 degrees.

CONCLUSION: Six months after implantation of the toric multifocal IOL, patients had significantly reduced SE and refractive cylinder, good visual acuity across distances, increased reading speed, and minimal IOL rotation.

FINANCIAL DISCLOSURE: No author has a financial or proprietary interest in any material or method mentioned.

 

结论:多焦点人工晶体植入术六个月后,患者的等效球镜度数和柱镜屈光度明显下降,各距离视力明显改善,增加阅读速度,且Toric IOL旋转非常少。

学科代码:外科学 眼科学   关键词:Alcon AcrySof多焦点人工晶体双侧植入术后的临床结 ,全球精选文摘 爱思唯尔医学网, Elseviermed
顶一下(0
您可能感兴趣的文章
    发表评论网友评论(0)
      发表评论
      登录后方可发表评论,点击此处登录